Irinotecan Injection

Irinotecan Injection

Categories : Oncology

Product Packaging : Single Vial

Product Composition : 40mg/2ml, 100mg/5ml

Irinotecan Injection is a widely used topoisomerase I inhibitor anticancer (chemotherapy) injectable formulation indicated for the treatment of various solid tumors, especially gastrointestinal cancers. Irinotecan works by inhibiting the topoisomerase I enzyme, leading to DNA damage and preventing cancer cell replication.

This oncology injectable is an essential component in modern chemotherapy regimens and is frequently used in combination therapies for improved clinical outcomes. The injectable formulation ensures precise dosing, rapid systemic action, and controlled administration in oncology settings.

Manufactured under stringent sterile and oncology-grade conditions, Irinotecan Injection offered by Genliva Wellness LLP ensures high purity, safety, and consistent quality. As a trusted Irinotecan Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused third-party manufacturing, private label injectable solutions, and global bulk supply.

Send Message

Irinotecan Injection is a widely used topoisomerase I inhibitor anticancer (chemotherapy) injectable formulation indicated for the treatment of various solid tumors, especially gastrointestinal cancers. Irinotecan works by inhibiting the topoisomerase I enzyme, leading to DNA damage and preventing cancer cell replication.

This oncology injectable is an essential component in modern chemotherapy regimens and is frequently used in combination therapies for improved clinical outcomes. The injectable formulation ensures precise dosing, rapid systemic action, and controlled administration in oncology settings.

Manufactured under stringent sterile and oncology-grade conditions, Irinotecan Injection offered by Genliva Wellness LLP ensures high purity, safety, and consistent quality. As a trusted Irinotecan Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused third-party manufacturing, private label injectable solutions, and global bulk supply.

Irinotecan Injection is commonly used in the treatment of:

  • Colorectal cancer
  • Metastatic colorectal cancer (advanced stages)
  • Gastrointestinal cancers
  • Pancreatic cancer (in combination therapy)
  • Other solid tumors as per clinical protocols

This chemotherapy injection is administered under strict medical supervision in oncology settings.

Injectable dosage form offers key advantages in oncology care:


whatsapp-app